ZA978842B - Use of an H<+>, K<+>-ATPase inhibitor in the treatment of nasal polyps. - Google Patents

Use of an H<+>, K<+>-ATPase inhibitor in the treatment of nasal polyps.

Info

Publication number: ZA978842B
Authority: ZA; South Africa
Prior art keywords: treatment; nasal polyps; atpase inhibitor; atpase; inhibitor
Prior art date: 1996-10-11

Application number

ZA9708842A

Other languages

English (en)

Inventor

Per Lindberg

Jordi Serra-Carreras

Joan Pinas-Masso

Jan Trofast

Original Assignee

Astra Ab

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1996-10-11

Filing date

1997-10-02

Publication date

1998-04-14

1997-10-02 Application filed by Astra Ab filed Critical Astra Ab

1998-04-14 Publication of ZA978842B publication Critical patent/ZA978842B/xx

Links

229940121819 ATPase inhibitor Drugs 0.000 title 1
208000000592 Nasal Polyps Diseases 0.000 title 1
239000000362 adenosine triphosphatase inhibitor Substances 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/444—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

Health & Medical Sciences (AREA)
General Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Pulmonology (AREA)
Pain & Pain Management (AREA)
Rheumatology (AREA)
Otolaryngology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Plural Heterocyclic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Steroid Compounds (AREA)

ZA9708842A 1996-10-11 1997-10-02 Use of an H<+>, K<+>-ATPase inhibitor in the treatment of nasal polyps. ZA978842B (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
SE9603725A SE9603725D0 (sv)	1996-10-11	1996-10-11	New teatment

Publications (1)

Publication Number	Publication Date
ZA978842B true ZA978842B (en)	1998-04-14

Family

ID=20404214

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
ZA9708842A ZA978842B (en)	1996-10-11	1997-10-02	Use of an H<+>, K<+>-ATPase inhibitor in the treatment of nasal polyps.

Country Status (33)

Country	Link
EP (1)	EP0946175B1 (pl)
JP (1)	JP4100713B2 (pl)
KR (1)	KR100510812B1 (pl)
CN (1)	CN1146416C (pl)
AR (1)	AR008886A1 (pl)
AT (1)	ATE230597T1 (pl)
AU (1)	AU738310B2 (pl)
BR (1)	BR9711896A (pl)
CA (1)	CA2268305C (pl)
CZ (1)	CZ298799B6 (pl)
DE (1)	DE69718347T2 (pl)
DK (1)	DK0946175T3 (pl)
EE (1)	EE04043B1 (pl)
ES (1)	ES2188995T3 (pl)
HU (1)	HUP0000036A3 (pl)
ID (1)	ID23692A (pl)
IL (1)	IL129324A0 (pl)
IS (1)	IS1930B (pl)
MY (1)	MY117918A (pl)
NO (1)	NO321007B1 (pl)
NZ (1)	NZ334786A (pl)
PL (1)	PL190902B1 (pl)
PT (1)	PT946175E (pl)
RS (1)	RS49599B (pl)
RU (1)	RU2197966C2 (pl)
SA (1)	SA97180641B1 (pl)
SE (1)	SE9603725D0 (pl)
SK (1)	SK284252B6 (pl)
TR (1)	TR199900770T2 (pl)
TW (1)	TW568784B (pl)
UA (1)	UA59374C2 (pl)
WO (1)	WO1998016228A1 (pl)
ZA (1)	ZA978842B (pl)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6489346B1 (en)	1996-01-04	2002-12-03	The Curators Of The University Of Missouri	Substituted benzimidazole dosage forms and method of using same
US5840737A (en)	1996-01-04	1998-11-24	The Curators Of The University Of Missouri	Omeprazole solution and method for using same
ID27345A (id)	1998-08-18	2001-04-05	Univ California	Pencegahan produksi lendir jalan udara dengan antagonis egf-r
US6846799B1 (en) *	1998-08-18	2005-01-25	The Regents Of The University Of California	Preventing airway mucus production by administration of EGF-R antagonists
US7354894B2 (en)	1998-08-18	2008-04-08	The Regents Of The University Of California	Preventing airway mucus production by administration of EGF-R antagonists
SI1180378T1 (sl) *	1999-03-03	2011-04-29	Optinose As	Nazalni aplikator
US20050020637A1 (en) *	2001-11-19	2005-01-27	Wolfgang-Alexander Simon	Agents for the treatment of airway disorders
EP1487447A1 (en) *	2002-03-14	2004-12-22	ALTANA Pharma AG	Use of proton pump inhibitors for the treatment of airway disorders
PL373000A1 (pl) *	2002-05-07	2005-08-08	Altana Pharma Ag	Kombinacja inhibitora pompy protonowej i środka leczniczego do dróg oddechowych do leczenia chorób dróg oddechowych
JP2005528418A (ja) *	2002-05-07	2005-09-22	アルタナ　ファルマ　アクチエンゲゼルシャフト	気道疾患を治療するための新規組み合わせ
FR2845915B1 (fr) *	2002-10-21	2006-06-23	Negma Gild	Utilisation du tenatoprazole pour le traitement du reflux gastro-oesophagien
PT1572217E (pt)	2002-12-12	2008-11-28	Nycomed Gmbh	Medicamento combinado de r,r-formoterol e ciclesonida
US8993599B2 (en)	2003-07-18	2015-03-31	Santarus, Inc.	Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US8371292B2 (en)	2003-09-16	2013-02-12	Nycomed Gmbh	Use of ciclesonide for the treatment of respiratory diseases
RU2252025C1 (ru) *	2003-11-28	2005-05-20	Дальневосточный государственный медицинский университет	Способ лечения избыточной грануляционной ткани гортани и трахеи
US8906940B2 (en)	2004-05-25	2014-12-09	Santarus, Inc.	Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
CN104408249B (zh) *	2014-11-24	2017-09-26	广州供电局有限公司	单芯电缆导体热性参数的确定方法及系统
KR101974504B1 (ko) *	2017-04-10	2019-05-03	재단법인 아산사회복지재단	호산구성 비용종 동물모델

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB1429184A (en) *	1972-04-20	1976-03-24	Allen & Hanburys Ltd	Physically anti-inflammatory steroids for use in aerosols
GB1571629A (en) *	1977-11-30	1980-07-16	Fisons Ltd	Pharmaceutical compositions containing beclomethasone dipropionate

1996
- 1996-10-11 SE SE9603725A patent/SE9603725D0/xx unknown
1997
- 1997-01-10 UA UA99042004A patent/UA59374C2/uk unknown
- 1997-10-01 TR TR1999/00770T patent/TR199900770T2/xx unknown
- 1997-10-01 CN CNB971985847A patent/CN1146416C/zh not_active Expired - Fee Related
- 1997-10-01 IL IL12932497A patent/IL129324A0/xx not_active IP Right Cessation
- 1997-10-01 JP JP51824698A patent/JP4100713B2/ja not_active Expired - Fee Related
- 1997-10-01 WO PCT/SE1997/001651 patent/WO1998016228A1/en not_active Ceased
- 1997-10-01 DE DE69718347T patent/DE69718347T2/de not_active Expired - Fee Related
- 1997-10-01 AT AT97945135T patent/ATE230597T1/de not_active IP Right Cessation
- 1997-10-01 CA CA002268305A patent/CA2268305C/en not_active Expired - Fee Related
- 1997-10-01 EP EP97945135A patent/EP0946175B1/en not_active Expired - Lifetime
- 1997-10-01 EE EEP199900118A patent/EE04043B1/xx not_active IP Right Cessation
- 1997-10-01 RS YUP-163/99A patent/RS49599B/sr unknown
- 1997-10-01 PT PT97945135T patent/PT946175E/pt unknown
- 1997-10-01 RU RU99109596/14A patent/RU2197966C2/ru not_active IP Right Cessation
- 1997-10-01 AU AU46409/97A patent/AU738310B2/en not_active Ceased
- 1997-10-01 ES ES97945135T patent/ES2188995T3/es not_active Expired - Lifetime
- 1997-10-01 SK SK384-99A patent/SK284252B6/sk unknown
- 1997-10-01 NZ NZ334786A patent/NZ334786A/xx unknown
- 1997-10-01 KR KR10-1999-7003115A patent/KR100510812B1/ko not_active Expired - Fee Related
- 1997-10-01 BR BR9711896A patent/BR9711896A/pt not_active Application Discontinuation
- 1997-10-01 ID IDW990139D patent/ID23692A/id unknown
- 1997-10-01 CZ CZ0122999A patent/CZ298799B6/cs not_active IP Right Cessation
- 1997-10-01 DK DK97945135T patent/DK0946175T3/da active
- 1997-10-01 PL PL332692A patent/PL190902B1/pl not_active IP Right Cessation
- 1997-10-01 HU HU0000036A patent/HUP0000036A3/hu unknown
- 1997-10-02 ZA ZA9708842A patent/ZA978842B/xx unknown
- 1997-10-07 MY MYPI97004697A patent/MY117918A/en unknown
- 1997-10-07 TW TW086114622A patent/TW568784B/zh not_active IP Right Cessation
- 1997-10-08 AR ARP970104655A patent/AR008886A1/es unknown
- 1997-11-23 SA SA97180641A patent/SA97180641B1/ar unknown
1999
- 1999-04-06 NO NO19991619A patent/NO321007B1/no unknown
- 1999-04-08 IS IS5021A patent/IS1930B/is unknown

Also Published As

Publication number	Publication date
EP0946175A1 (en)	1999-10-06
BR9711896A (pt)	1999-08-24
DE69718347D1 (de)	2003-02-13
NO991619D0 (no)	1999-04-06
IS5021A (is)	1999-04-08
RS49599B (sr)	2007-06-04
JP2001508034A (ja)	2001-06-19
HUP0000036A2 (hu)	2002-05-29
IS1930B (is)	2004-05-18
ES2188995T3 (es)	2003-07-01
NO991619L (no)	1999-04-06
AU738310B2 (en)	2001-09-13
UA59374C2 (uk)	2003-09-15
CA2268305C (en)	2006-11-28
PT946175E (pt)	2003-04-30
KR20000049046A (ko)	2000-07-25
DE69718347T2 (de)	2003-08-28
NO321007B1 (no)	2006-02-27
SA97180641B1 (ar)	2005-12-18
KR100510812B1 (ko)	2005-08-31
HU0000036D0 (pl)	2002-05-29
CZ298799B6 (cs)	2008-02-06
DK0946175T3 (da)	2003-03-17
WO1998016228A1 (en)	1998-04-23
RU2197966C2 (ru)	2003-02-10
PL332692A1 (en)	1999-09-27
AU4640997A (en)	1998-05-11
EE04043B1 (et)	2003-06-16
SK38499A3 (en)	2000-03-13
SK284252B6 (sk)	2004-12-01
AR008886A1 (es)	2000-02-23
CZ122999A3 (cs)	1999-09-15
EE9900118A (et)	1999-10-15
EP0946175B1 (en)	2003-01-08
NZ334786A (en)	2000-12-22
CN1232397A (zh)	1999-10-20
CA2268305A1 (en)	1998-04-23
JP4100713B2 (ja)	2008-06-11
HK1022848A1 (en)	2000-08-25
MY117918A (en)	2004-08-30
CN1146416C (zh)	2004-04-21
PL190902B1 (pl)	2006-02-28
YU16399A (sh)	2000-03-21
IL129324A0 (en)	2000-02-17
SE9603725D0 (sv)	1996-10-11
ID23692A (id)	2000-05-11
TR199900770T2 (xx)	1999-06-21
ATE230597T1 (de)	2003-01-15
HUP0000036A3 (en)	2003-02-28
TW568784B (en)	2004-01-01

Publication	Publication Date	Title
ZA991489B (en)	1999-09-30	Oxaliplatin solution formulations and the method of use thereof.
ZA97631B (en)	1997-08-04	Migraine treatment.
IL129324A0 (en)	2000-02-17	Use of an H<+>, K<+>-ATPase inhibitor in the treatment of nasal polyps
SI1304327T1 (pl)	2005-08-31
CY2429B1 (en)	2004-11-12	Substituted 3,5-diphenyl-1,2,4-triazoles and theiruse as pharmaceutical metal chelators.
MXPA03004504A (es)	2003-09-05	Sistemas de tratamiento oral.
ZA993364B (en)	2000-12-01	Novel 4-phenylpiperidines for the treatment of pruritic dermatoses.
MXPA03002861A (es)	2003-07-14	Nuevos retinoides para tratamiento del enfisema.
ZA200307102B (en)	2004-09-13	The use of enmantiomeric pure escitalopram.
AU1772399A (en)	1999-08-02	Well treatment
ZA973622B (en)	1997-11-25	Use of forms of hyaluronic acid (HA) for the treatment of cancer.
ZA200105690B (en)	2002-09-25	Novel treatment.
ZA978640B (en)	1998-03-27	Use of 1-hydroxy-2-pyridones for the treatment of saborrheic dermatitis.
AU3896899A (en)	1999-11-29	Compositions for the treatment of tumors, and uses thereof
MXPA03004017A (es)	2004-02-12	Metodo para el tratamiento de inflamacion.
Green	1998	Traditional norms of masculinity
ZA99253B (en)	2000-07-14	Treatment of waxes.
ZA200109120B (en)	2003-11-13	Use of Arylalkanoylpyridazines.
ZA991786B (en)	1999-09-06	Therapeutic treatment for asthma.
EP1032266A4 (en)	2003-07-16	USE OF DELTA-5-ANDROSTEN-3-BETA-OL-7,17-DION IN THE TREATMENT OF ARTHRITIS
FR2715206B3 (fr)	1996-05-15	Robinet.
AP2005003432A0 (en)	2005-12-31	Novel method of treatment.
ZA994585B (en)	2001-01-15	Treatment of water.
ZA9810329B (en)	2000-05-11	"Water treatment means".
ZA200007258B (en)	2001-06-07	Use of optically pure (+)-norcisapride for treating apnea, bulimia and other disorders.